1. Home
  2. POCI vs INTS Comparison

POCI vs INTS Comparison

Compare POCI & INTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Optics Corporation Inc.

POCI

Precision Optics Corporation Inc.

N/A

Current Price

$4.07

Market Cap

32.4M

Sector

Health Care

ML Signal

N/A

Logo Intensity Therapeutics Inc.

INTS

Intensity Therapeutics Inc.

HOLD

Current Price

$0.41

Market Cap

24.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POCI
INTS
Founded
1982
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.4M
24.0M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
POCI
INTS
Price
$4.07
$0.41
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$4.33
AVG Volume (30 Days)
21.4K
3.2M
Earning Date
11-13-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$21,575,039.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.67
N/A
52 Week Low
$3.77
$0.19
52 Week High
$5.34
$3.17

Technical Indicators

Market Signals
Indicator
POCI
INTS
Relative Strength Index (RSI) 40.71 47.29
Support Level $4.05 $0.40
Resistance Level $4.24 $0.46
Average True Range (ATR) 0.21 0.06
MACD -0.02 -0.01
Stochastic Oscillator 21.67 22.53

Price Performance

Historical Comparison
POCI
INTS

About POCI Precision Optics Corporation Inc.

Precision Optics Corp Inc is engaged in designing, developing, and manufacturing advanced optical instruments. It manufactures medical products such as endoscopes and endocouplers which incorporate various optical technologies for use in a variety of minimally invasive surgical and diagnostic procedures. The company also produces endoscopes for various applications as well as designs and manufactures custom optical medical devices to satisfy customers' specific requirements. In addition, the company manufactures and sells components and assemblies specially designed for industrial and military use. The company earns the majority of its revenue from the United States.

About INTS Intensity Therapeutics Inc.

Intensity Therapeutics Inc is a clinical-stage biotechnology company pioneering a new immune-based approach to treat solid tumor cancers. The company leverages its DfuseRxtechnology platform to create new, proprietary drug formulations that, following direct injection, rapidly disperse throughout a tumor and diffuse therapeutic agents into cancer cells. Intensity's product candidates have the potential to induce an adaptive systemic immune response that not only attacks the injected tumor, but also non-injected tumors. Their pipeline is focused on realizing the full potential of INT230-6 in metastatic and local disease settings to help cancer patients with unmet medical need.

Share on Social Networks: